Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 261,937 | 206,872 | 128,258 | 92,877 | 53,639 |
| Operating Income | -261,937 | -206,872 | -128,258 | -92,877 | -53,639 |
| Other Income | 2,356 | 9,316 | 4,678 | 813 | 745 |
| Pre-tax Income | -259,581 | -197,556 | -123,580 | -92,064 | -52,894 |
| Net Income Continuous | -259,581 | -197,556 | -123,580 | -92,064 | -52,894 |
| Net Income | $-259,581 | $-197,556 | $-123,580 | $-92,064 | $-52,894 |
| EPS Basic Total Ops | -1.88 | -1.59 | -1.27 | -1.41 | -1.85 |
| EPS Basic Continuous Ops | -1.88 | -1.59 | -1.27 | -1.41 | -0.96 |
| EPS Diluted Total Ops | -1.88 | -1.59 | -1.27 | -1.41 | -1.85 |
| EPS Diluted Continuous Ops | -1.88 | -1.59 | -1.27 | -1.41 | -0.96 |
| EPS Diluted Before Non-Recurring Items | -1.88 | -1.59 | N/A | N/A | N/A |
| EBITDA(a) | $-258,932 | $-209,124 | $-128,634 | $-91,906 | $-52,735 |